These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18647549)

  • 1. The combined effect of ultrasound exposure and cisplatin on human ovarian carcinoma cells A2780.
    Bernard V; Skorpíková J; Mornstein V
    Folia Biol (Praha); 2008; 54(3):97-101. PubMed ID: 18647549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological effects of combined ultrasound and cisplatin treatment on ovarian carcinoma cells.
    Bernard V; Skorpíková J; Mornstein V; Slaninová I
    Ultrasonics; 2010 Mar; 50(3):357-62. PubMed ID: 19740505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of free cisplatin in medium by differential pulse polarography after ultrasound and cisplatin treatment of a cancer cell culture.
    Bernard V; Fojt L; Skorpíková J; Mornstein V
    Indian J Biochem Biophys; 2011 Feb; 48(1):59-62. PubMed ID: 21469604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of near field ultrasound on carboplatin treatment of ovarian carcinoma cells.
    Bernard V; Mornstein V; Bourek A
    Indian J Biochem Biophys; 2013 Aug; 50(4):284-8. PubMed ID: 24772947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circumvention of cisplatin resistance in ovarian cancer by combination of cyclosporin A and low-intensity ultrasound.
    Yu T; Yang Y; Zhang J; He H; Ren X
    Eur J Pharm Biopharm; 2015 Apr; 91():103-10. PubMed ID: 25668779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcome of Cisplatin Resistance in Ovarian Cancer by Combination of Low-intensity Ultrasound and Cisplatin.
    Kip B; Aydin O
    Curr Drug Deliv; 2023; 20(9):1380-1390. PubMed ID: 35761504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound and cisplatin combined treatment of human melanoma cells A375--the study of sonodynamic therapy.
    Bernard V; Mornstein V; Škorpíková J; Jaroš J
    Ultrasound Med Biol; 2012 Jul; 38(7):1205-11. PubMed ID: 22502893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model.
    Zhao H; Wei W; Sun Y; Gao J; Wang Q; Zheng J
    DNA Cell Biol; 2015 Jan; 34(1):55-62. PubMed ID: 25211326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols.
    Bratasz A; Selvendiran K; Wasowicz T; Bobko A; Khramtsov VV; Ignarro LJ; Kuppusamy P
    J Transl Med; 2008 Feb; 6():9. PubMed ID: 18302761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MCT1 promotes the cisplatin-resistance by antagonizing Fas in epithelial ovarian cancer.
    Yan C; Yang F; Zhou C; Chen X; Han X; Liu X; Ma H; Zheng W
    Int J Clin Exp Pathol; 2015; 8(3):2710-8. PubMed ID: 26045776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sanguinarine enhances cisplatin sensitivity via glutathione depletion in cisplatin-resistant ovarian cancer (A2780) cells.
    Sarkhosh-Inanlou R; Molaparast M; Mohammadzadeh A; Shafiei-Irannejad V
    Chem Biol Drug Des; 2020 Feb; 95(2):215-223. PubMed ID: 31512406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulforaphane enhances the cisplatin sensitivity through regulating DNA repair and accumulation of intracellular cisplatin in ovarian cancer cells.
    Gong TT; Liu XD; Zhan ZP; Wu QJ
    Exp Cell Res; 2020 Aug; 393(2):112061. PubMed ID: 32437713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced antitumor activity of irofulven in combination with 5-fluorouracil and cisplatin in human colon and ovarian carcinoma cells.
    Poindessous V; Koeppel F; Raymond E; Cvitkovic E; Waters SJ; Larsen AK
    Int J Oncol; 2003 Nov; 23(5):1347-55. PubMed ID: 14532976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between p-cofilin and cisplatin resistance in patients with ovarian cancer and the role of p-cofilin in prognosis.
    Qin Y; Li W; Long Y; Zhan Z
    Cancer Biomark; 2019; 24(4):469-475. PubMed ID: 30932883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of cisplatin sensitivity in human ovarian carcinoma A2780 and SKOV3 cell lines by sulforaphane.
    Hunakova L; Gronesova P; Horvathova E; Chalupa I; Cholujova D; Duraj J; Sedlak J
    Toxicol Lett; 2014 Nov; 230(3):479-86. PubMed ID: 25159039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro Ultrasonic Potentiation of 2-Phenylethynesulfonamide/Magnetic Fluid Hyperthermia Combination Treatments for Ovarian Cancer.
    Mérida F; Rinaldi C; Juan EJ; Torres-Lugo M
    Int J Nanomedicine; 2020; 15():419-432. PubMed ID: 32021188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired cisplatin resistance in human ovarian A2780 cancer cells correlates with shift in taurine homeostasis and ability to volume regulate.
    Sørensen BH; Thorsteinsdottir UA; Lambert IH
    Am J Physiol Cell Physiol; 2014 Dec; 307(12):C1071-80. PubMed ID: 25252947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
    Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
    Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
    Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G
    Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer.
    Ehlén A; Brennan DJ; Nodin B; O'Connor DP; Eberhard J; Alvarado-Kristensson M; Jeffrey IB; Manjer J; Brändstedt J; Uhlén M; Pontén F; Jirström K
    J Transl Med; 2010 Aug; 8():78. PubMed ID: 20727170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.